Skip to main content

Table 2 Comparision of the incidence of lipidemia between breast cancer patients and control group

From: Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy

Parameter Breast cancer (n = 1054) Control group (n = 2483)
TC (Mean ± SD, mmol/L) TG (Mean ± SD, mmol/L) HDL-C (Mean ± SD, mmol/L) LDL-C (Mean ± SD, mmol/L) Dyslipidemia (n, %) TC (Mean ± SD, mmol/L) TG (Mean ± SD, mmol/L) HDL-C (Mean ± SD, mmol/L) LDL-C (Mean ± SD, mmol/L) Dyslipidemia (n, %)
Total 4.47 ± 0.93** 1.27 ± 1.02* 1.43 ± 0.36** 2.80 ± 0.81** 453(42.98)** 5.01 ± 0.95 1.33 ± 0.86 1.48 ± 0.32 3.19 ± 0.87 1447(58.28)
Age stratification (years) 20–39 4.04 ± 0.83* 0.95 ± 0.54 1.45 ± 0.34 2.43 ± 0.73 33(25.58) 4.27 ± 0.70 0.94 ± 0.44 1.47 ± 0.29 2.52 ± 0.65 78(22.41)
40–49 4.32 ± 0.85** 1.14 ± 0.67* 1.43 ± 0.33* 2.69 ± 0.76** 150(34.88)** 4.84 ± 0.84 1.25 ± 0.90 1.49 ± 0.32 3.03 ± 0.78 447(49.72)
50–59 4.67 ± 1.02** 1.45 ± 1.53 1.42 ± 0.40** 2.94 ± 0.84** 149(52.84)** 5.34 ± 0.92 1.44 ± 0.88 1.51 ± 0.35 3.47 ± 0.86 540(74.07)
≥60 4.78 ± 0.88** 1.47 ± 0.91 1.45 ± 0.39 3.04 ± 0.79** 121(56.81)** 5.34 ± 0.95 1.59 ± 0.84 1.44 ± 0.31 3.51 ± 0.87 382(75.35)
  1. *p < 0.05 **p < 0.001 comparison of lipid levels and dyslipidemia incidence between breast cancer patients and control group; TC: total-cholesterol, TG: triglyceride, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol